Search This Blog

Wednesday, September 30, 2020

Raymond James sees 62% upside for Acadia Healthcare

Acadia Healthcare (ACHC +4.5%) has received Strong Buy rating from Raymond James, up from Outperform with a price target of $48, up from $40.

The analyst believes after the divestiture of its U.K. portfolio, investors will be able to re-focus on the underlying value of the U.S. business, led by the "sleeper" CTC business, which the analyst estimate accounts for ~20% of US EBITDA at a 13x estimated base case EBITDA multiple.

Recently, Acadia notified potential buyers, that it will relaunch a formal sale process.

https://seekingalpha.com/news/3618567-raymond-james-sees-62-upside-for-acadia-healthcare

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.